Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TotalEnergies
TTE
|
+$988M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$354M |
| 3 |
BP
BP
|
+$285M |
| 4 |
Freeport-McMoran
FCX
|
+$269M |
| 5 |
Rio Tinto
RIO
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$612M |
| 2 |
BAY
BAYER AG SPONS ADR
BAY
|
+$441M |
| 3 |
Johnson & Johnson
JNJ
|
+$247M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$189M |
| 5 |
Vodafone
VOD
|
+$164M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.26% |
| 2 | Financials | 13.72% |
| 3 | Healthcare | 11.39% |
| 4 | Consumer Discretionary | 8.65% |
| 5 | Energy | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.5B
| $1.36M | ﹤0.01% |
40,967
+18,032
| +79% | +$601K |
|
502
iShares MSCI Switzerland ETF
EWL
$2.19B
| $1.36M | ﹤0.01% |
+39,178
| New | +$1.34M |
|
503
Ring Energy
REI
$320M
| $1.35M | ﹤0.01% |
136,000
-26,597
| -16% | -$319K |
|
504
Vipshop
VIPS
$7.47B
| $1.35M | ﹤0.01% |
215,721
| – | – |
|
505
CVS Health
CVS
$134B
| $1.34M | ﹤0.01% |
17,049
-300,626
| -95% | -$21.5M |
|
|
ARRY
506
DELISTED
Array Biopharma Inc
ARRY
| $1.34M | ﹤0.01% |
88,256
-32,320
| -27% | -$495K |
|
|
QTS
507
DELISTED
QTS REALTY TRUST, INC.
QTS
| $1.32M | ﹤0.01% |
30,957
+1,421
| +5% | +$62K |
|
508
Lennar Class B
LEN.B
$20.1B
| $1.3M | ﹤0.01% |
35,490
-2,663
| -7% | -$108K |
|
|
IMGN
509
DELISTED
Immunogen Inc
IMGN
| $1.3M | ﹤0.01% |
136,949
+141
| +0.1% | +$1.35K |
|
510
B&G Foods
BGS
$290M
| $1.29M | ﹤0.01% |
47,175
-8,164
| -15% | -$253K |
|
511
iShares Global Financials ETF
IXG
$683M
| $1.28M | ﹤0.01% |
19,490
-422
| -2% | -$27.9K |
|
512
Toronto Dominion Bank
TD
$200B
| $1.27M | ﹤0.01% |
20,842
+408
| +2% | +$24.3K |
|
|
EGRX
513
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $1.24M | ﹤0.01% |
17,925
-2,827
| -14% | -$214K |
|
514
Trane Technologies
TT
$101B
| $1.24M | ﹤0.01% |
12,112
-9
| -0.1% | -$880 |
|
515
Southside Bancshares
SBSI
$972M
| $1.24M | ﹤0.01% |
35,527
-13,071
| -27% | -$462K |
|
|
ESRX
516
DELISTED
Express Scripts Holding Company
ESRX
| $1.2M | ﹤0.01% |
12,641
-403,815
| -97% | -$34.4M |
|
|
AGN
517
DELISTED
Allergan plc
AGN
| $1.17M | ﹤0.01% |
6,129
+28
| +0.5% | +$5.14K |
|
518
DuPont de Nemours
DD
$19.1B
| $1.17M | ﹤0.01% |
7,150
+931
| +15% | +$160K |
|
519
iShares Core MSCI EAFE ETF
IEFA
$191B
| $1.15M | ﹤0.01% |
+17,967
| New | +$1.15M |
|
520
Netflix
NFLX
$305B
| $1.13M | ﹤0.01% |
30,250
+6,840
| +29% | +$248K |
|
521
Enanta Pharmaceuticals
ENTA
$377M
| $1.04M | ﹤0.01% |
12,214
-2,469
| -17% | -$247K |
|
522
National Beverage
FIZZ
$2.95B
| $1.04M | ﹤0.01% |
17,890
+28
| +0.2% | +$1.57K |
|
523
Banc of California
BANC
$3.05B
| $1.02M | ﹤0.01% |
54,073
-11,148
| -17% | -$220K |
|
524
Lantheus
LNTH
$6.59B
| $996K | ﹤0.01% |
66,648
-33,410
| -33% | -$488K |
|
525
APA Corp
APA
$13B
| $952K | ﹤0.01% |
19,963
+5,417
| +37% | +$244K |
|
Similar funds
Ken Fisher's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Fisher held 943 positions worth $82.4B, up 6.9% from $77B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Fisher's Q3 2018 filing shows 81 new, 327 increased, 378 reduced and 73 closed positions. Its largest new stake was Adobe: 408,693 shares worth $110M. The largest sale was Berkshire Hathaway Class B, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2018 buy was Adobe: 408,693 shares worth $110M.
- Ken Fisher added most to TotalEnergies in Q3 2018, an estimated $988M increase.
- Ken Fisher's biggest Q3 2018 reduction was Berkshire Hathaway Class B, cutting an estimated $612M.
- Ken Fisher fully exited Cavium, Inc. in Q3 2018, selling an estimated $56.9M.
- Ken Fisher's ten largest holdings make up 27% of its $82.4B portfolio in Q3 2018.
- Ken Fisher opened 81 new positions and closed 73 in Q3 2018.
- Ken Fisher's portfolio value rose 6.9% quarter-over-quarter to $82.4B.
Based on Fisher Asset Management's 13F filing for Q3 2018, filed 24 Oct 2018.